DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus

Information source: AstraZeneca
Information obtained from ClinicalTrials.gov on August 08, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypertension

Phase: N/A

Status: Recruiting

Sponsored by: AstraZeneca

Official(s) and/or principal investigator(s):
Hyunah Caroline Choi, Study Director, Affiliation: AstraZeneca Korea

Overall contact:
AstraZeneca Korea Clinical Study, Information, Phone: 82-2-2188-2142, Email: myunghwan.chi@astrazeneca.com

Summary

To evaluate compliance and patients' satisfaction in mono and combination treatment of Candesartan cilexetil (Atacand)/ Candesartan cilexetil 16mg, hydrochlorothiazide 12. 5mg (Atacand plus) in hypertension.

Clinical Details

Official title: A Prospective, Non-Interventional, Observational, Multi-Center Trial to Evaluate Compliance and Efficacy in Mono and Combination Treatment of Candesartan Cilexetil(Atacand)/ Candesartan Cilexetil 16mg, Hydrochlorothiazide 12.5mg(Atacand Plus) in Hypertension

Study design: Natural History, Longitudinal, Defined Population, Prospective Study

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

1. Patients who have consented to participation/data release in this study

2. Patients diagnosed with hypertension and prescribed with atacand/atacand plus by the physician based on clinical decision

Exclusion Criteria:

1. Secondary hypertension requiring therapy other than antihypertensive medication

2. Patients not prescribed with atacand/atacand plus based on safety reasons or any other reason as determined by the physician

3. Women in pregnancy or lactation

4. Patients enrolled in any other studies

Locations and Contacts

AstraZeneca Korea Clinical Study, Information, Phone: 82-2-2188-2142, Email: myunghwan.chi@astrazeneca.com

Research Site, Seoul, Jongro-gu, Korea, Republic of; Recruiting

Research Site, Seoul, Kangnam-gu, Korea, Republic of; Recruiting

Research Site, Seoul, Songpa-gu, Korea, Republic of; Recruiting

Additional Information

Starting date: July 2007
Last updated: September 6, 2007

Page last updated: August 08, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009